Dow Up 0.08% Nasdaq Down 0.30%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
1.70 Up 0.02(1.19%) Sep 19, 4:00PM EDT
|After Hours : 1.67 Down 0.03 (1.76%) Sep 19, 4:02PM EDT
Prev Close:1.68
Open:1.69
Bid:1.30 x 700
Ask:2.00 x 3000
1y Target Est:6.50
Beta:-0.002
Next Earnings Date:N/A
Day's Range:1.60 - 1.75
52wk Range:1.36 - 5.61
Volume:81,466
Avg Vol (3m):168,997
Market Cap:56.08M
P/E (ttm):N/A
EPS (ttm):-1.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KBIOUp 1.19%56.08M
VRTXUp 6.57%24.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,262.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.31
Quarterly EPS Est (Sep-14) :-0.34
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback